Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.0%

32 terminated/withdrawn out of 529 trials

Success Rate

86.9%

+0.4% vs industry average

Late-Stage Pipeline

9%

47 trials in Phase 3/4

Results Transparency

0%

0 of 213 completed trials have results

Key Signals

88 recruiting25 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
245(78.0%)
Phase 3
27(8.6%)
Phase 4
20(6.4%)
Phase 2
17(5.4%)
Phase 1
4(1.3%)
Early Phase 1
1(0.3%)
314Total
N/A(245)
Phase 3(27)
Phase 4(20)
Phase 2(17)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (529)

Showing 20 of 529 trials
NCT06863974Not ApplicableRecruiting

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

Role: lead

NCT07541183Not Yet Recruiting

eQuoL Effectiveness Study

Role: collaborator

NCT07542990Phase 3Not Yet Recruiting

Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care

Role: collaborator

NCT05450783Recruiting

Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy

Role: collaborator

NCT06963151Not ApplicableNot Yet Recruiting

Association of a HABIT-ILE Course and a Home Programme on the Bimanual Performance of Children With Cerebral Palsy

Role: collaborator

NCT05337059Not ApplicableCompleted

Feasabilty and Physiological Effects of a Ventilation Strategy Combining PEEP and Tidal Volume Titration According to Inspiratory and Expiratory Transpulmonary Pressures in ARDS Patients.

Role: lead

NCT07506291Not ApplicableNot Yet Recruiting

HOME-PE2 : Home Treatment Versus Hospitalization in Patients With Acute Pulmonary Embolism, no Clinical Severity Criteria, and Either Right Ventricular Dysfunction or Elevated Troponin: a Randomized Controlled Trial

Role: lead

NCT06007391Phase 2Active Not Recruiting

Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1

Role: lead

NCT06036888Completed

DEFILE-QoL5 - Evaluation of the Long-term Surgical Management of the Thoraco-brachial Displacement Syndrome

Role: lead

NCT07499661Not ApplicableNot Yet Recruiting

Pulmonary Embolism in Patients With Acute Heart Failure: A Pragmatic Cluster-Randomized Trial (PEHF Study)

Role: lead

NCT06971848Not ApplicableNot Yet Recruiting

Evaluation of Skin Tests in Biotherapy Allergies

Role: lead

NCT07479849Not ApplicableNot Yet Recruiting

TACTILE : Validation of a Teleconsultation-Based Predictive Score for the Diagnosis of Acute Appendicitis in Children Using Artificial Intelligence Methods

Role: lead

NCT06807892Not ApplicableRecruiting

Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients

Role: lead

NCT07028476Not ApplicableRecruiting

New Care Pathway Using Automated Dynamic Laximetry

Role: lead

NCT05510128Not ApplicableTerminated

Evaluation of the Effectiveness of a Protocol for the Management of Female Functional Urinary Signs

Role: lead

NCT07470294Not Yet Recruiting

Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Population

Role: lead

NCT01648556Not ApplicableCompleted

Research of Predictive Factors to Immune Thrombopenic Purpura

Role: collaborator

NCT07468565Not Yet Recruiting

Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES)

Role: lead

NCT06990659Not ApplicableRecruiting

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

Role: lead

NCT02010229Completed

Clinical Situations at High Risk of Placenta Accreta / Percreta

Role: collaborator